Literature DB >> 25601610

Tumor volume as a prognostic factor was superior to the seventh edition of the pT classification in resectable gastric cancer.

N Jiang1, J-Y Deng1, X-W Ding1, Y Liu1, H Liang2.   

Abstract

PURPOSE: To demonstrate that the seventh edition of the tumor-node-metastasis (TNM) classification for gastric cancer (GC) should be updated with the tumor volume (pTV) for the improvement of its prognostic prediction accuracy.
METHODS: A total of 497 stage TNM I-III GC patients who underwent curative gastrectomy between January 2003 and December 2007 in our center were enrolled in this study. pTV equals to (tumor diameter/2)(2) × pT stage.
RESULTS: In the step 1 multivariate analysis, depth of invasion (pT) was confirmed to be an independent prognostic factors. However, when pTV was included in the step 2 multivariate analysis, pTV classification became significant, while pT classification disappeared. pT classification was substituted by pTV. For patients in each of the pT, significant differences in survival could always be observed among patients in different pTV classification. For patients in each pTV classification, prognosis was highly homologous between those in different pT classifications. TNM classification and the tumor volume-node-metastasis (TvNM) classification were directly compared for convenience. We found the TvNM classification (HR = 1.687, P < 0.001) was the most appropriately prognostic classification for predicting the OS of gastric cancer patients after curative surgery.
CONCLUSIONS: pTV maybe an independent prognostic factor in overall survival in GC, and pTV staging system maybe more reliable than the Union International Center Cancer and American Joint Committee (UICC/AJCC) on cancer pT system for prognostic assessment. pTV should be recommended as an important clinicopathologic variable for enhancement the accuracy of the prognostic prediction of GC patients in clinic.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Depth of tumor invasion (pT); Gastric cancer (GC); Overall survival (OS); Prognosis; Tumor volume (pTV)

Mesh:

Year:  2014        PMID: 25601610     DOI: 10.1016/j.ejso.2014.11.045

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  6 in total

Review 1.  Adjuvant radiochemotherapy for gastric cancer: Should we use prognostic factors to select patients?

Authors:  Linda Agolli; Riccardo Maurizi Enrici; Mattia Falchetto Osti
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

2.  The tumor-to-breast volume ratio (TBR) predicts cancer-specific survival in breast cancer patients who underwent modified radical mastectomy.

Authors:  Jiahuai Wen; Feng Ye; Xiaojia Huang; Shuaijie Li; Lu Yang; Xiangsheng Xiao; Xiaoming Xie
Journal:  Tumour Biol       Date:  2015-12-17

3.  Tumor volume increases the predictive accuracy of prognosis for gastric cancer: A retrospective cohort study of 3409 patients.

Authors:  Zhen Liu; Peng Gao; Shushang Liu; Gaozan Zheng; Jianjun Yang; Li Sun; Liu Hong; Daiming Fan; Hongwei Zhang; Fan Feng
Journal:  Oncotarget       Date:  2017-03-21

4.  Improvement of T stage precision by integration of surgical and pathological staging in radically resected stage pT3-pT4b gastric cancer.

Authors:  Hong-Hu Wang; Kai Li; Hao Xu; Zhe Sun; Zhen-Ning Wang; Hui-Mian Xu
Journal:  Oncotarget       Date:  2017-07-11

5.  Prognostic influence of 3-dimensional tumor volume on breast cancer compared to conventional 1-dimensional tumor size.

Authors:  Ki-Tae Hwang; Wonshik Han; Sang Mok Lee; Jaewoo Choi; Jongjin Kim; Jiyoung Rhu; Young A Kim; Dong-Young Noh
Journal:  Ann Surg Treat Res       Date:  2018-09-28       Impact factor: 1.859

6.  Post-therapy pathologic tumor volume predicts survival in gastric cancer patients who underwent neoadjuvant chemotherapy and gastrectomy.

Authors:  Xiaolong Tang; Qingsi He; Hui Qu; Guorui Sun; Jia Liu; Lei Gao; Jingbo Shi; Jianhong Ye; Yahang Liang
Journal:  BMC Cancer       Date:  2019-08-13       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.